Reuters logo
BRIEF-Santhera's Raxone receives first positive EAMS scientific opinion from UK's MHRA in Duchenne muscular dystrophy
2017年6月22日 / 凌晨5点08分 / 3 个月前

BRIEF-Santhera's Raxone receives first positive EAMS scientific opinion from UK's MHRA in Duchenne muscular dystrophy

June 22 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* SANTHERA‘S RAXONE RECEIVES FIRST POSITIVE EAMS SCIENTIFIC OPINION FROM UK‘S MHRA IN DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below